Noninvasive Aspergillus Pulmonary Disease

Seminars in Respiratory and Critical Care Medicine

Volumn 25, Issue 2, 2004, Pages 203-219

  Judson, Marc A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Allergic bronchopulmonary aspergillosis; Aspergilloma; Aspergillus; Azoles; Corticosteroids; Therapy

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; FUNGUS ANTIGEN; ITRACONAZOLE; PYRROLE DERIVATIVE;

ALLERGIC REACTION; ASPERGILLOSIS; ASPERGILLUS; ASTHMA; BRONCHIECTASIS; BRONCHOPULMONARY ASPERGILLOMA; CLINICAL TRIAL; DISEASE ASSOCIATION; HEMOPTYSIS; HUMAN; IMMUNE RESPONSE; LUNG ASPERGILLOSIS; LUNG FUNCTION; LUNG INJURY; LUNG LOBECTOMY; NONHUMAN; PRIORITY JOURNAL; RADIODIAGNOSIS; RESPIRATORY TRACT DISEASE; REVIEW; THORAX SURGERY; TREATMENT INDICATION;

EID: 2142805918     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-824904     Document Type: Review

References (152)

1. Stevens DA, Kan VL, Judson MA, et al. Practice guidelines for disease caused by Aspergillus. Clin Infect Dis 2000;30:696-709
2. Gerson SL, Talbot GH, Hurwitz S, et al. Prolonged granulocytopenia: the major risk factor fsor invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984;100:345-351
3. Wald A, Leisenring W, van Burik JA, et al. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997;175:1459-1466
4. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994;19 (suppl 1):S33-S40
5. Denning DW, Follansbee SE, Scolaro M, et al. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:654-662
6. Stevens DA, Schwartz HJ, Lee JY, et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 2000;342:756-762
7. Shah A, Khan ZU, Charturvedi S, et al. Allergic bronchopulmonary aspergillosis with coexistent aspergilloma: a long-term follow-up. J Asthma 1989;26:109-115
8. Judson MA. Allergic bronchopulmonary aspergillosis. Pulmonary Critical Care Update 2003;17:lesson 17
9. Vlahakis NE, Aksamit TR. Diagnosis and treatment of allergic bronchopulmonary aspergillosis. Mayo Clin Proc 2001;76:930-938
10. Schuyler MR. Allergic bronchopulmonary aspergillosis. Clin Chest Med 1983;4:15-22
11. Patterson R, Greenberger PA, Harris KE. Allergic bronchopulmonary aspergillosis [editorial]. Chest 2000;118:7-8
12. Hinson KF, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis. Thorax 1952;7:317-333
13. Greenberger P. Allergic bronchopulmonary aspergillosis. Clin Allergy Immunol 2002;16:449-468
14. Ricketti AJ, Greenberger PA, Patterson R. Immediate-type reactions in patients with allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 1983;71:541-545
15. Malo JL, Hawkins R, Pepys J. Studies in chronic allergic bronchopulmonary aspergillosis: clinical and physiological findings. Thorax 1977;32:254-261
16. Varkey B. Allergic bronchopulmonary aspergillosis: clinical perspectives. Immunol Allergy Clin North Am 1998;18:480-501
17. Graves TS, Fink JN, Patterson R, Kurup VP, Scanlon GT. A familial occurrence of allergic bronchopulmonary aspergillosis. Ann Intern Med 1979;91:378-382
18. Halwig MJ, Kurup VP, Greenberger PA, Patterson R. A familial occurrence of allergic bronchopulmonary aspergillosis: a probable environmental source. J Allergy Clin Immunol 1985;76:55-59
19. Eaton T, Garretr J, Milne D, Frankel A, Wells AU. Allergic bronchopulmonary aspergillosis in an asthma clinic. Chest 2000;118:66-72
20. Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M. Allergic bronchopulmonary aspergillosis: natural history and classification of early disease by serologic and roentegographic studies. Arch Intern Med 1986;146:916-918
21. Basich JE, Graves TS, Nasir Baz M, et al. Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics. J Allergy Clin Immunol 1981;68:98-102
22. Mrouch S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 1994;105:32-36
23. Neppmuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Chest 1999;115:364-370
24. McCarthy DS, Simon G, Hargreave FE. The radiological appearances in allergic bronchopulmonary aspergillosis. Clin Radiol 1970;21:366-375
25. Neeld DA, Goodman LR, Gurney JW, et al. Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1990;142:1200-1205
26. Lynch DA. Imagine of asthma and allergic bronchopulmonary mycosis. Radiol Clin North Am 1998;36:129-142
27. Malo JP, Pepys J, Simon G. Studies in chronic allergic bronchopulmonary aspergillosis, II: Radiological findings. Thorax 1977;32:262-268
28. Phelan MS, Kerr IH. Allergic bronchopulmonary aspergillosis: the radiological appearance during long-term follow-up. Clin Radiol 1984;35:385-392
29. Ward S, Heyneman L, Lee MJ, et al. Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol 1999;173:937-942
30. Mitchell TAM, Hamilos DL, Lynch DA, Newell JD. Distribution and severity of bronchiectasis in allergic bronchopulmonary aspergillosis. J Asthma 2000;37:65-72
31. Crameri R, Hemmann S, Ismail C, Menz G, Blaser K. Disease-specific recombinant allergens for the diagnosis of allergic bronchopulmonary aspergillosis. Int'l Immunol 1998;10:1211-1216
32. Banerjee B, Kurup VP, Greenberger PA, Johnson BD, Fink JN. Cloning and expression of Aspergillus fumigatus allergen Asp f 16 mediating both humoral and cell-mediated immunity in allergic bronchopulmonary asgergillosis (ABPA). Clin Exp Allergy 2001;31:761-770
33. Madan T, Banerjee B, Bhatnagar PK, Shah A, Sarma PU. Identification of 45kD antigen in immune complexes of patients of allergic bronchopulmonary aspergillosis. Mol Cell Biochem 1997;166:111-116
34. Crameri R. Molecular cloning of Aspergillus fumigatus allergens and their role in allergic bronchopulmonary aspergillosis. Chem Immunol 2002;81:73-93
35. Kurup VP, Grunig G, Knutsen AP, Murali PS. Cytokines in allergic bronchopulmonary aspergillosis. Res Immunol 1998; 149:466-477
36. Kahn S, McClellan JS, Knutsen AP. Increased sensitivity to IL-4 in patients with allergic bronchopulmonary aspergillosis. Int'l Arch Allergy Immunol 2000;123:319-326
37. Chauhan B, Santiago L, Hutcheson PS, et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000;106:723-729
38. Cockrill BA, Hales CA. Allergic bronchopulmonary aspergillosis. Annu Rev Med 1999;50:303-316
39. Ricketti AJ, Greenberger PA, Mintzer RA, Patterson R. Allergic bronchopulmonary aspergillosis. Arch Intern Med 1983;143:1553-1557
40. Elliott MW, Taylor JN. Allergic bronchopulmonary aspergillosis. Clin Exp Allergy 1997;27(suppl 1):55-59
41. Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis: model of bronchopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease. Chest 1987;91(suppl):165S-171S
42. Rosenberg M, Patterson R, Roberts M, Wang J. The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis. Am J Med 1978;64:599-606
43. Greenberger PA, Patterson R. Diagnosis and management of allergic bronchopulmonary aspergillosis. Ann Allergy 1986;56:444-448
44. Sahn SA, Lakshminarayan S. Allergic bronchopulmonary penicillosis. Chest 1973;63:286-288
45. Hoshino H, Tagaki S, Kon H, et al. Allergic bronchopulmonary aspergillosis due to Aspergillus niger without bronchial asthma. Respiration 1999;66:369-372
46. Rajkumar DC. Evaluation of allergic bronchopulmonary aspergillosis in patients with and without central bronchiectasis. J Asthma 2002;39:473-477
47. Shah A, Panjabi C. Allergic bronchopulmonary aspergillosis: a review of a disease with a worldwide distribution. J Asthma 2002;39:273-289
48. Wark PAB, Gibson PG. Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment. Respirology 2001;6:1-7
49. Capewell S, Chapman BJ, Alexander F, Greening AP, Crompton GK. Corticosteroid treatment and prognosis in pulmonary eosinophilia. Thorax 1989;44:925-929
50. Safirstein BH, D'Sousa MF, Simon G, Tai EHC, Pepys J. Five-year follow-up of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1973;108:450-459
51. Middleton WG, Paterson IC, Grant IWB, Douglas AC. Asthmatic pulmonary eosinophilia: a review of 65 cases. Br J Dis Chest 1977;71:115-122
52. Wang JL, Patterson R, Roberts M, Ghory AC. The management of allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1979;120:87-92
53. Fink JN. Allergic bronchopulmonary aspergillosis. Chest 1985;87(suppl):81S-84S
54. Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977;86:405-414
55. McCarthy DS, Pepys J. Allergic bronchopulmonary aspergillosis: clinical immunology, II: Skin, nasal and bronchial tests. Clin Allergy 1971;1:415-432
56. Report to the Research Committee of the British Thoracic Society Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis. Br J Dis Chest 1979;73:349-356
57. Hilton AM, Chatterjee SS. Bronchopulmonary aspergillosis: treatment with beclomethasone dipropionate. Postgrad Med J 1975;51(suppl 4):98-103
58. Seaton A, Seaton RA, Wightman AJA. Management of allergic bronchopulmonary aspergillosis. Q J Med 1994;87:529-537
59. Leon EE, Craig TJ. Antifungals in the treatment of allergic bronchopulmonary aspergillosis. Ann Allergy Asthma Immunol 1999;82:511-517
60. Germand P, Tuchais E. Allergic bronchopulmonary aspergillosis treated with itraconazole. Chest 1995;107:883
61. Pacheco A, Martin JA, Cuevas M. Serologic response to itraconazole in allergic bronchopulmonary aspergillosis. Chest 1993;103:980-981
62. De Beule K, De Doncher P, Cauwenbergh G, et al. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results and open label study (1982-1987). Mycoses 1988;31:476-485
63. Chabasse D, Tuchais E, Bouchara JP, De Gentile L, Tuchais N. Efficacite de l'itraconazole dans le traitment de l'aspergillosis broncho-pulmonare allergique (ABPA), a propos de 2 observations. Bull Soc Fr Myc Med 1990;19:271-275
64. Nikaido Y, Nagata N, Yamamoto T, Yoshii C, Ohmori H, Kido N. A case of allergic bronchopulmonary aspergilosis successfully treated with itraconazole. Respir Med 1998;92:118-119
65. Matsuzaki Y, Jimi T, Tao Y, Takada S, Miyazaki N. Allergic bronchopulmonary aspergillosis successfully treated with itraconazole (Japanese). Nihon Kyobu Shikkan Gakkai Zasshi 1997;35:352-356
66. Salez F, Brichet A, Desurmont S, Grosbois J-M, Wallert B, Tuonnel A-B. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 1999;116:1665-1668
67. Mannes GP, van der Heide S, van Aalderen WM, Gerritsen J. Itraconazole and allergic bronchopulmonary aspergillosis in two brothers with cystic fibrosis. Lancet 1993;341:492
68. Lebeau B, Pelloux H, Pinel C, et al. Itraconazole in the treatment of aspergillosis: a study of 16 cases. Mycoses 1994; 37:171-179
69. Denning DW, Van Wye JE, Lewiston NJ, Stevens DA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991;100:813-819
70. Measaki S, Iwakawa J, Higashiyama Y, et al. Antifungal activity of a new triazole, voriconazole (UK-109496), against clinical isolates of Aspergillus spp. J Infect Chemother 2000; 6:101-103
71. Pfaller MA, Messer SA, Hollis RJ, Jones RN. Sentry Participants Group. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY antimicrobial surveillance program, 2000. Antimicrob Agents Chemother 2002;46:1032-1037
72. National Asthma Education and Prevention Program. Expert panel report, 2: Guidelines for the diagnosis and management of asthma; clinical practice guidelines, component 3. Bethesda, MD: National Institutes of Health; 1997. Publication no, 97-405
73. Radin RC, Greenberger PA, Patterson R, Ghory A. Mould counts and exacerbations of allergic bronchopulmonary aspergillosis. Clin Allergy 1983;13:271-275
74. Hanley-Lopez J, Clement LT. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Curr Opin Pulm Med 2000;6:540-544
75. Mastella G, Rainisio M, Harms HK, et al. Epidemiologic Registry of Cystic Fibrosis: allergic bronchopulmonary aspergillosis in cystic fibrosis: a European epidemiological study. Eur Respir J 2000;16:464-471
76. Geller DE, Kaplowitz H, Light M, Colin AA. Epidemiologic Study of Cystic Fibrosis: allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Chest 1999;116:639-646
77. Hutcheson PS, Rejent AJ, Slavin RG. Variability in parameters of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. J Allergy Clin Immunol 1991; 88:390-394
78. Moss RB. Allergic bronchopulmonary aspergillosis. Clin Rev Allergy Immunol 2002;23:87-104
79. Skov M, Hoiby N, Koch C. Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Allergy 2002;57:723-728
80. Miller PW, Hamosh A, Macek M, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet 1996;59:45-51
81. Marchand E, Verellen-Dumoulin C, Maresse M, et al. Frequency of cystic fibrosis transmembrane conductance regulator gene mutations and 5T allele in patients with allergic bronchopulmonary aspergillosis. Chest 2001;119:762-767
82. Eaton TE, Weiner Miller P, Garrett JE, Cutting GR. Cystic fibrosis transmembrane conductance regulator gene mutations: do they play a role in the etiology of allergic bronchopulmonary aspergillosis? Clin Exp Allergy 2002; 32:756-761
83. Fraser R, Pare J, Pare P, et al. Diagnosis of diseases of the chest. 3rd ed. Philadelphia: WB Saunders; 1998
84. British Tuberculosis and Thoracic Association. Aspergilloma and residual tuberculosis cavities: the result of a resurvey. Tubercle 1970;51:227-245
85. Libshitz HI, Atkinson GW, Israel HL. Pleural thickening as a manifestation of Aspergillus superinfection. AJR Am J Roentgenol 1974;120:883-886
86. Glimp RA, Bayer AS. Pulmonary aspergilloma: diagnostic and therapeutic considerations. Arch Intern Med 1983; 143:303-308
87. Rafferty P, Biggs B, Crompton GK, et al. What happens to patients with pulmonary aspergilloma? Thorax 1983;38:579-583
88. Andrews CP, Weiner MH. Aspergillus antigen detection in bronchoalveolar lavage fluid from patients with invasive aspergillosis and aspergilloma. Am J Med 1982;73:372-380
89. Smith RL, Morelli MJ, Aranda CP. Pulmonary aspergilloma diagnosed by fiberoptic bronchoscopy. Chest 1987;92:948-949
90. Severo LC, Londero AT, Picon PD, Rizzon CF, Tarasconi JC. Petriellidium boydii fungus ball in a patient with active tuberculosis. Mycopathologia 1982;77:15-17
91. Goldberg B. Radiological appearances in pulmonary aspergillosis. Clin Radiol 1962;13:106-114
92. Irwin A. Radiology of the aspergilloma. Clin Radiol 1966;18:432-438
93. Kathuria SK, Rippon J. Non-Aspergillus aspergilloma. Am J Clin Pathol 1982;78:870-873
94. McCarthy DS, Peppys J. Pulmonary aspergilloma: clinical immunology. Clin Allergy 1973;3:57-70
95. Wollschlager C, Kahn F. Aspergillomas complicating sarcoidosis: a prospective study of 100 patients. Chest 1984;86:585-588
96. Torpoco JO, Yousuffuddin M, Pate JW. Aspergilloma within a malignant pulmonary cavity. Chest 1976;69:561-563
97. Makker H, McConnochie K, Gibbs AR. Postirradiation pulmonary fibrosis complicated by aspergilloma and bronchocentric granulomatosis. Thorax 1989;44:676-677
98. Solit RW, McKeown JJ, Smullens S. The surgical implications of intracavitary mycetomas (fungus balls). J Thorac Cardiovasc Surg 1971;62:411-422
99. Joynson DHM. Pulmonary aspergilloma. Br J Clin Pract 1977;31:207-216
100. Schwartz J, Baum GL, Straub M. Cavitary histoplasmosis complicated by fungus ball. Am J Med 1961;31:692-700
101. Sarosi GA, Silberfarb PM, Saliba NA, et al. Aspergillomas occurring in blastomycotic cavities. Am Rev Respir Dis 1971;104:581-584
102. Haslock I. Ankylosing spondylitis. Baillieres Clin Rheumatol 1993;7:99-115
103. Bruce RA. A case of pulmonary aspergillosis. Tubercle 1957; 38:203-205
104. Flye MW, Sealy WC. Pulmonary aspergilloma: a report of its occurrence in two patients with cyanotic heart disease. Ann Thorac Surg 1975;20:196-203
105. Aslam PA, Eastridge CE, Hughes FA. Aspergillosis of the lung: an 18-year experience. Chest 1971;59:28-32
106. Addrizzo-Harris DJ, Harkin TJ, McGuinness G, et al. Pulmonary aspergilloma and AIDS. Chest 1997;111:612-618
107. Shah A, Khan ZU, Chaturvedi S, Malik GB, Randhawa HS. Concomitant allergic Aspergillus sinusitis and allergic bronchopulmonary aspergillosis associated with familial occurrence allergic bronchopulmonary aspergillosis. Ann Allergy 1990; 64:507-512
108. Pimentel JC. Pulmonary calcification in the tumor-like form of pulmonary aspergillosis; pulmonary aspergilloma. Am Rev Respir Dis 1966;94:208-216
109. Campbell MJ, Clayton YM. Bronchopulmonary aspergillosis: a correlation of clinical and laboratory findings in 272 patients investigated for bronchopulmonary aspergillosis. Am Rev Respir Dis 1964;89:186-196
110. Hilvering C, Stevens EAM, Orie NGM. Fever in aspergillus mycetoma. Thorax 1970;25:19-24
111. Binder RE, Faling LJ, Putatch RD, et al. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine 1982;60:109-124
112. Faulkner SL, Vernon R, Brown PP, et al. Hemoptysis and pulmonary aspergilloma: operative versus nonoperative treatment. Ann Thorac Surg 1978;25:389-392
113. Lewis MM, Mortelliti MP, Yeager H Jr, Tsou E. Clinical bronchiectasis complicating pulmonary sarcoidosis: a case series of seven patients. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:154-159
114. Tomlinson J, Sahn SA. Aspergilloma in sarcoidosis and tuberculosis. Chest 1987;92:505-508
115. Tomee J, VanDer Werf T, Latge J, et al. Serologic monitoring of disease and treatment in a patient with pulmonary aspergilloma. Am J Respir Crit Care Med 1995; 151:199-204
116. Kauffman C. Quandary about treatment of aspergillomas persists. Thorax 1996;347:1640
117. Daly RC, Pairolero PC, Piehler JM, et al. Pulmonary aspergilloma: results of treatment. J Thorac Cardiovasc Surg 1986;92:981-988
118. Soltanzadeh H, Wychulis AR, Sadr F, et al. Surgical treatment of aspergilloma. Ann Surg 1977;186:13-16
119. Jewkes J, Kay PH, Paneth M, et al. Pulmonary aspergilloma: analysis of prognosis in relation to hemoptysis and survey of treatment. Thorax 1983;38:572-578
120. Garvey J, Crastnopol P, Weisz D, et al. The surgical treatment of pulmonary aspergillomas. J Thorac Cardiovasc Surg 1977;74:642-647
121. Israel HL, Lenchner GS, Atkinson GW. Sarcoidosis and aspergilloma: the role of surgery. Chest 1982;82:430-432
122. Kaestel M, Meyer W, Mittelmeier HO, et al. Pulmonary aspergilloma: clinical findings and surgical treatment. Thorac Cardiovasc Surg 1999;47:340-345
123. Massard G, Roeslin N, Wihlm JM, et al. Pleuropulmonary aspergilloma: clinical spectrum and results of surgical treatment. Ann Thorac Surg 1992;54:1159-1164
124. Conlan AA, Abramor E, Moyes DG. Pulmonary aspergilloma: indications for surgical intervention: an analysis of 22 cases. S Afr Med J 1987;71:285-288
125. Battaglini JW, Murray GF, Kaegy BA, et al. Surgical management of symptomatic pulmonary aspergilloma. Ann Thorac Surg 1985;39:512-516
126. Kay PH. Surgical management of pulmonary aspergilloma [editorial]. Thorax 1997;52:753-754
127. Chen JC, Chang YL, Luh SP, et al. Surgical treatment for pulmonary aspergilloma: a 28-year experience. Thorax 1997; 52:810-813
128. Chatzimichalis A, Massard G, Kessler R, et al. Bronchopulmonary aspergilloma: a reappraisal. Ann Thorac Surg 1998;65:927-929
129. Oakley RE, Petrou M, Goldstraw P. Indications and outcome of surgery for pulmonary aspergilloma. Thorax 1997;52:813-815
130. Giron JM, Poey CG, Fajadet PP, et al. Inoperable pulmonary aspergilloma: percutaneous CT-guided injection with glycerin and amphotericin B paste in 15 cases. Radiology 1993;188:825-827
131. Jackson M, Flower CDR, Shneerson JM. Treatment of symptomatic pulmonary aspergillomas with intracavitary instillation of amphotericin B through an indwelling catheter. Thorax 1993;48:928-930
132. Munk PL, Vellet AD, Rankin RN, et al. Intracavitary aspergilloma: transthoracic percutaneous injection of amphotericin B solution. Radiology 1993;188:821-823
133. Lee KS, Kim HT, Kim YH, et al. Treatment of hemoptysis in patients with cavitary aspergilloma of the lung: value of percutaneous instillation of amphotericin B. AJR Am J Roentgenol 1993;161:727-731
134. Klein JS, Fang K, Chang MC. Percutaneous transcatheter treatment of an intracavitary aspergilloma. Cardiovasc Intervent Radiol 1993;16:321-324
135. Yamada H, Kohno S, Koga H, et al. Topical treatment of pulmonary aspergilloma by antifungals. Chest 1993;103:1421-1425
136. Hargis JL, Bone RC, Stewart J, et al. Intracavitary amphotericin B in the treatment of symptomatic pulmonary aspergillomas. Am J Med 1980;68:389-394
137. Rumbak M, Kohler G, Eastrige C, et al. Topical treatment of life-threatening hemoptysis from aspergillomas. Thorax 1996;51:253-255
138. Guleria R, Gupta D, Jindal SK. Treatment of pulmonary aspergilloma by endoscopic intracavitary instillation of ketoconazole. Chest 1993;103:1301-1302
139. Kaplan J, Johns CJ. Mycetomas in pulmonary sarcoidosis: nonsurgical management. J Hopkins Med J 1979;145:157-161
140. Remy J, Arnaud A, Fardou H, et al. Treatment of hemoptysis by embolization of bronchial arteries. Radiology 1977;122:33-37
141. Uflacker R, Kaemmerer A, Neves C, et al. Management of massive hemoptysis by bronchial artery embolization. Radiology 1983;146:627-634
142. Falkson C, Sur R, Pacella J. External beam radiotherapy: a treatment option for massive hemoptysis caused by mycetoma. Clin Oncol 2002;14:233-235
143. Shneerson JM, Emerson PA, Phillips RH. Radiotherapy for massive hemoptysis from an aspergilloma. Thorax 1980;35:953-954
144. Mikami M, Nakamura S, Kawakami M. Pulmonary aspergilloma successfully treated with long-term intermittent inhalation therapy with miconazole. Intern Med 1993;32:247-250
145. Hammerman KH, Sarosi GA, Tosh FE. Amphotericin B in the treatment of saprophytic forms of pulmonary aspergillosis. Am Rev Respir Dis 1974;109:57-62
146. Van Cutsem J, Van Gerven F, Vam De Ven MA, et al. Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother 1984;26:615-619
147. Jennings TS, Hardin TC. Treatment of aspergillosis with itraconazole. Ann Pharmacother 1993;27:1206-1211
148. Campbell JH, Winter JH, Richardson MD, et al. Treatment of pulmonary aspergilloma with itraconazole. Thorax 1991;46:839-841
149. Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 1990;23:607-614
150. Impens N, De Greve J, DeBeule K, et al. Oral treatment with itraconazole of aspergilloma in cavitary lung cancer. Eur Respir J 1990;3:837-839
151. Tsubura E. Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma. Kekkaku 1997;72:557-564
152. Judson MA. Diagnosis and management of aspergilloma. Pulmonary Critical Care Update 2002;15:1-14